AIM IMMUNOTECH INC. Gain (Loss) on Sale of Derivatives
AIM IMMUNOTECH INC. (AIM) reported Gain (Loss) on Sale of Derivatives of -$32.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnSaleOfDerivatives · last filed 2026-08-07
- AIM IMMUNOTECH INC. gain (loss) on sale of derivatives for the quarter ending 2026-06-30 was $0.00.
- AIM IMMUNOTECH INC. gain (loss) on sale of derivatives for the quarter ending 2026-03-31 was -$32.00K.
- AIM IMMUNOTECH INC. gain (loss) on sale of derivatives for the quarter ending 2025-12-31 was -$434.00K.
- AIM IMMUNOTECH INC. gain (loss) on sale of derivatives for the quarter ending 2025-09-30 was -$3.98M.
- AIM IMMUNOTECH INC. gain (loss) on sale of derivatives for fiscal 2025 was -$4.41M.
- AIM IMMUNOTECH INC. gain (loss) on sale of derivatives for fiscal 2024 was -$458.00K.
| Period end | Gain (Loss) on Sale of Derivatives 3 month | Gain (Loss) on Sale of Derivatives 6 month | Gain (Loss) on Sale of Derivatives 9 month | Gain (Loss) on Sale of Derivatives 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$32.00K 10-Q · filed 2026-08-07 | -$466.00K derived: sum of 3 quarters · filed 2026-08-07 | -$4.44M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$32.00K 10-Q · filed 2026-05-15 | -$466.00K derived: sum of 2 quarters · filed 2026-05-15 | -$4.44M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | -$434.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$4.41M derived: sum of 2 quarters · filed 2026-03-27 | -$4.41M 10-K · filed 2026-03-27 | |
| 2025-09-30 | -$3.98M 10-Q · filed 2025-11-17 | -$3.98M 10-Q · filed 2025-11-17 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-11-17 | -$458.00K derived: sum of 3 quarters · filed 2025-11-17 | -$458.00K 10-K · filed 2025-03-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$458.00K derived: sum of 2 quarters · filed 2025-11-17 | -$458.00K 10-Q · filed 2025-11-17 | |
| 2024-06-30 | -$458.00K 10-Q · filed 2025-08-14 | -$458.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |